ID   ARLS_STAA8              Reviewed;         451 AA.
AC   Q9KJN3; Q2FYM0;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   07-JAN-2015, entry version 104.
DE   RecName: Full=Signal transduction histidine-protein kinase ArlS;
DE            EC=2.7.13.3;
GN   Name=arlS; OrderedLocusNames=SAOUHSC_01419;
OS   Staphylococcus aureus (strain NCTC 8325).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=10869073; DOI=10.1128/JB.182.14.3955-3964.2000;
RA   Fournier B., Hooper D.C.;
RT   "A new two-component regulatory system involved in adhesion,
RT   autolysis, and extracellular proteolytic activity of Staphylococcus
RT   aureus.";
RL   J. Bacteriol. 182:3955-3964(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W.,
RA   Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC 8325 genome.";
RL   (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL   Gram positive pathogens, 2nd edition, pp.381-412, ASM Press,
RL   Washington D.C. (2006).
RN   [3]
RP   FUNCTION.
RX   PubMed=10633099; DOI=10.1128/JB.182.3.664-671.2000;
RA   Fournier B., Aras R., Hooper D.C.;
RT   "Expression of the multidrug resistance transporter NorA from
RT   Staphylococcus aureus is modified by a two-component regulatory
RT   system.";
RL   J. Bacteriol. 182:664-671(2000).
RN   [4]
RP   FUNCTION, AND REGULATION.
RX   PubMed=11454217; DOI=10.1046/j.1365-2958.2001.02515.x;
RA   Fournier B., Klier A., Rapoport G.;
RT   "The two-component system ArlS-ArlR is a regulator of virulence gene
RT   expression in Staphylococcus aureus.";
RL   Mol. Microbiol. 41:247-261(2001).
RN   [5]
RP   REGULATION BY MGRA.
RX   PubMed=12791130; DOI=10.1046/j.1365-2958.2003.03503.x;
RA   Ingavale S.S., Van Wamel W., Cheung A.L.;
RT   "Characterization of RAT, an autolysis regulator in Staphylococcus
RT   aureus.";
RL   Mol. Microbiol. 48:1451-1466(2003).
RN   [6]
RP   REGULATION BY SARV.
RX   PubMed=15292128; DOI=10.1128/JB.186.16.5267-5280.2004;
RA   Manna A.C., Ingavale S.S., Maloney M., van Wamel W., Cheung A.L.;
RT   "Identification of sarV (SA2062), a new transcriptional regulator, is
RT   repressed by SarA and MgrA (SA0641) and involved in the regulation of
RT   autolysis in Staphylococcus aureus.";
RL   J. Bacteriol. 186:5267-5280(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=15528666; DOI=10.1099/mic.0.27194-0;
RA   Fournier B., Klier A.;
RT   "Protein A gene expression is regulated by DNA supercoiling which is
RT   modified by the ArlS-ArlR two-component system of Staphylococcus
RT   aureus.";
RL   Microbiology 150:3807-3819(2004).
RN   [8]
RP   FUNCTION IN BIOFILM DEVELOPMENT.
RX   PubMed=16030226; DOI=10.1128/JB.187.15.5318-5329.2005;
RA   Toledo-Arana A., Merino N., Vergara-Irigaray M., Debarbouille M.,
RA   Penades J.R., Lasa I.;
RT   "Staphylococcus aureus develops an alternative, ica-independent
RT   biofilm in the absence of the arlRS two-component system.";
RL   J. Bacteriol. 187:5318-5329(2005).
CC   -!- FUNCTION: Member of the two-component regulatory system ArlS/ArlR
CC       involved in the regulation of adhesion, autolysis, multidrug
CC       resistance and virulence. ArlS probably functions as a sensor
CC       protein kinase which is autophosphorylated at a histidine residue
CC       and transfers its phosphate group to ArlR. ArlS/ArlR affects
CC       expression of the multidrug resistance transporter norA and
CC       interacts with both Agr (virulence accessory gene regulator)
CC       (negatively) and SarA (staphylococcal accessory regulator)
CC       (positively) to modulate several virulence factor genes, including
CC       ssp (serine protease), spa (surface protein A) and hla (alpha-
CC       hemolysin). Could inhibit biofilm development by a mechanism
CC       independent of the presence of the poly-N-acetylglucosamine
CC       (PNAG). Also, Arl proteins are required for the efficient activity
CC       of DNA gyrase inhibitors and high osmolarity on spa expression.
CC       {ECO:0000269|PubMed:10633099, ECO:0000269|PubMed:10869073,
CC       ECO:0000269|PubMed:11454217, ECO:0000269|PubMed:15528666,
CC       ECO:0000269|PubMed:16030226}.
CC   -!- CATALYTIC ACTIVITY: ATP + protein L-histidine = ADP + protein N-
CC       phospho-L-histidine.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}.
CC   -!- INDUCTION: Activated by agr, SarA, SarV and MgrA.
CC   -!- PTM: Autophosphorylated. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 HAMP domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00102}.
CC   -!- SIMILARITY: Contains 1 histidine kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00107}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF165314; AAF85897.1; -; Genomic_DNA.
DR   EMBL; CP000253; ABD30512.1; -; Genomic_DNA.
DR   RefSeq; WP_000166801.1; NC_007795.1.
DR   RefSeq; YP_499945.1; NC_007795.1.
DR   ProteinModelPortal; Q9KJN3; -.
DR   SMR; Q9KJN3; 180-447.
DR   STRING; 93061.SAOUHSC_01419; -.
DR   EnsemblBacteria; ABD30512; ABD30512; SAOUHSC_01419.
DR   GeneID; 3920650; -.
DR   KEGG; sao:SAOUHSC_01419; -.
DR   PATRIC; 19580277; VBIStaAur99865_1298.
DR   eggNOG; COG0642; -.
DR   HOGENOM; HOG000223177; -.
DR   OMA; INIWIAN; -.
DR   OrthoDB; EOG6G4VQG; -.
DR   BioCyc; SAUR93061:GIWJ-1359-MONOMER; -.
DR   Proteomes; UP000008816; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IEA:InterPro.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.287.130; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003661; EnvZ-like_dim/P.
DR   InterPro; IPR003660; HAMP_linker_domain.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR004358; Sig_transdc_His_kin-like_C.
DR   InterPro; IPR005467; Sig_transdc_His_kinase_core.
DR   InterPro; IPR009082; Sig_transdc_His_kinase_dimeric.
DR   Pfam; PF00672; HAMP; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00512; HisKA; 1.
DR   PRINTS; PR00344; BCTRLSENSOR.
DR   SMART; SM00304; HAMP; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SMART; SM00388; HisKA; 1.
DR   SUPFAM; SSF47384; SSF47384; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS50885; HAMP; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix; Two-component regulatory system;
KW   Virulence.
FT   CHAIN         1    451       Signal transduction histidine-protein
FT                                kinase ArlS.
FT                                /FTId=PRO_0000074688.
FT   TRANSMEM     11     31       Helical. {ECO:0000255}.
FT   TRANSMEM    156    176       Helical. {ECO:0000255}.
FT   DOMAIN      178    231       HAMP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00102}.
FT   DOMAIN      239    451       Histidine kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00107}.
FT   MOD_RES     242    242       Phosphohistidine; by autocatalysis.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00107}.
SQ   SEQUENCE   451 AA;  52400 MW;  6308576067A22438 CRC64;
     MTKRKLRNNW IIVTTMITFV TIFLFCLIII FFLKDTLHNS ELDDAERSSS DINNLFHSKP
     VKDISALDLN ASLGNFQEII IYDEHNNKLF ETSNDNTVRV EPGYEHRYFD RVIKKRYKGI
     EYLIIKEPIT TQDFKGYSLL IHSLENYDNI VKSLYIIALA FGVIATIITA TISYVFSTQI
     TKPLVSLSNK MIEIRRDGFQ NKLQLNTNYE EIDNLANTFN EMMSQIEESF NQQRQFVEDA
     SHELRTPLQI IQGHLNLIQR WGKKDPAVLE ESLNISIEEM NRIIKLVEEL LELTKGDVND
     ISSEAQTVHI NDEIRSRIHS LKQLHPDYQF DTDLTSKNLE IKMKPHQFEQ LFLIFIDNAI
     KYDVKNKKIK VKTRLKNKQK IIEITDHGIG IPEEDQDFIF DRFYRVDKSR SRSQGGNGLG
     LSIAQKIIQL NGGSIKIKSE INKGTTFKII F
//
